AURKA and plasma cell myeloma: Analysis of public GEO datasets showed that AURKA is overexpressed in patient-derived myeloma samples compared with normal controls, with especially elevated expression in plasma cell leukemia, where higher AURKA levels may be linked to worse outcomes.